AK0529
AK0529 is a pharmaceutical drug with 9 clinical trials. Currently 1 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
3
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
1
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of AK0529 in Adults Patients Hospitalized With RSV Infection
A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants
Viral Inhibition in Children for Treatment of RSV
A Study of AK0529 in Chinese Infants Hospitalized With RSV
A Study of AK0529 to Evaluate Pharmacokinetics and Safety in Chinese Healthy Volunteers
Clinical Trials (9)
A Study of AK0529 in Adults Patients Hospitalized With RSV Infection
A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants
Viral Inhibition in Children for Treatment of RSV
A Study of AK0529 in Chinese Infants Hospitalized With RSV
A Study of AK0529 to Evaluate Pharmacokinetics and Safety in Chinese Healthy Volunteers
Anti-RSV Study in Chinese Patients (ASCENT)
A Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of AK0529
A Study of AK0529 in Infants Hospitalized With RSV
Safety, Tolerability and PK Study of AK0529 in Healthy Human
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9